Lonazolac
![]() | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.053.428 |
| Chemical and physical data | |
| Formula | C17H13ClN2O2 |
| Molar mass | 312.75 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Lonazolac is a nonsteroidal anti-inflammatory drug (NSAID).
References
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams |
|
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
| Receptor (ligands) |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enzyme (inhibitors) | |||||||||||||||||
| Others | |||||||||||||||||
| |||||||||||||||||
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.
